首页 | 本学科首页   官方微博 | 高级检索  
     

质子泵抑制剂合理用药分析及专项整治工作建议
引用本文:陈虹,王营,谢昊霖,田泾. 质子泵抑制剂合理用药分析及专项整治工作建议[J]. 中国药事, 2018, 32(2): 275-282
作者姓名:陈虹  王营  谢昊霖  田泾
作者单位:上海长海医院, 上海 200433;白求恩国际和平医院, 石家庄 050082,白求恩医务士官学校, 石家庄 050081,一汽总医院吉林大学第四医院, 长春130011,上海长海医院, 上海 200433
摘    要:目的:回顾性分析我院住院患者2016年质子泵抑制剂(PPIs)的使用情况,了解PPIs在我院的合理应用情况,针对PPIs专项整治活动的开展提出建议。方法:调取2016年住院患者PPIs用药数据,包括药品名称、使用金额、临床诊断、用法用量、疗程、使用人数等,并对PPIs使用率排名前10位的临床科室随机抽取500份病历(50份/科)进行用药合理性分析。结果:我院PPIs的不合理使用存在的主要问题有无指征用药、品种选择不当、疗程过长、用法用量不合理、存在药物相互作用等。结论:应尽快开展PPIs专项整治活动。由行政部门制定点评方案并实施;由药剂科临床药学室具体开展PPIs专项整治工作,确定评价内容和抽检病历方案,并对不合理病历进行干预和点评后再干预工作;在PPIs专项整治工作早期开展宣传和培训工作,以期推动我院PPIs的合理应用。

关 键 词:质子泵抑制剂  合理用药  PPIs专项整治  艾司奥美拉唑  奥美拉唑  兰索拉唑  雷贝拉唑  泮托拉唑
收稿时间:2017-05-28

Analysis of Rational Use of Proton Pump Inhibitors and Suggestions for Special Rectification
Chen Hong,Wang Ying,Xie Haolin and Tian Jing. Analysis of Rational Use of Proton Pump Inhibitors and Suggestions for Special Rectification[J]. Chinese Pharmaceutical Affairs, 2018, 32(2): 275-282
Authors:Chen Hong  Wang Ying  Xie Haolin  Tian Jing
Affiliation:Shanghai Changhai Hospital, Shanghai 200433, China;Bethune International Peace Hospital, Shijiazhuang 050082, China,Bethune Military Medical College, Shijiazhuang 050081, China,The Fourth Hospital of Jilin University, FAW-general Hospital, Changchun 130011, China and Shanghai Changhai Hospital, Shanghai 200433, China
Abstract:Objective: To retrospectively analyze the application of proton pump inhibitors (PPIs) of inpatients in our hospital in 2016, to understand the situation of the rational use of PPIs, and to put forward Suggestions for the special rectifcation for PPIs. Methods: Data concerning the medication of PPIs of inpatients including drug name, amount of use, clinical diagnosis, usage and dosage, medical course, and number of users, etc. were collected. 500 medical records (50 per department) were randomly selected from the top 10 clinical departments by using PPIs and the rational use of PPIs was analyzed. Results: The main problem of the irrational use of PPIs consisted of medication without indication, inappropriate variety selection, long medical course, unreasonable usage and dosage as well as drug interactions. Conclusion: The special rectifcation for PPIs should be carried out as soon as possible. The review plan should be formulated and implemented by administrative departments. The special rectification work should be carried out by the division of clinical pharmacy of the department of pharmacy, such as the confrmation of evaluation content and the plan of sampling the medical records, reviewing the unreasonable medical records and the reevaluation. The publicity and training work should be carried out in the early stage of the special rectifcation in order to promote rational use of PPIs.
Keywords:proton pump inhibitor  rational drug use  special rectifcation for PPIs  esomeprazole  omeprazole  lansoprazole  rabeprazole  pantoprazole
点击此处可从《中国药事》浏览原始摘要信息
点击此处可从《中国药事》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号